Reconciling the clinical practice guidelines on Bell's palsy from the AAO-HNSF and the AAN.
Bell's palsy, named after the Scottish anatomist, Sir Charles Bell, is the most common acute mononeuropathy, or disorder affecting a single nerve, and is the most common diagnosis associated with facial nerve weakness/paralysis. In the past 2 years, both the American Academy of Neurology (AAN) and the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) have published clinical practice guidelines aimed to improve the quality of care and outcomes for patients diagnosed with Bell's palsy. This commentary aims to address the similarities and differences in the scope and final recommendations made by each guideline development group.
Virginia Mason Medical Center, Seattle, Washington, USA.
Seth R
SR
Schwartz
Stephanie L
SL
Jones
Thomas S D
TS
Getchius
Gary S
GS
Gronseth
D000998:Antiviral Agents / Q000627:therapeutic use*; D020330:Bell Palsy / Q000175:diagnosis* / Q000188:drug therapy* / Q000628:therapy*; D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D009462:Neurology / Q000592:standards*; D010036:Otolaryngology / Q000379:methods*; D017410:Practice Guidelines as Topic / Q000592:standards*; D013256:Steroids / Q000627:therapeutic use*
D000998:Antiviral Agents; D013256:Steroids
Bell’s palsy; facial nerve; guidelines; methodology